NCT05629065View on ClinicalTrials.gov

Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)

NAActive, not recruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

June 30, 2028

Conditions
Breast CancerGastrointestinal CancerGynecologic CancerThoracic CancerGenitourinary Cancer
Interventions
OTHER

Clinician Nudge Email

"-Clinician nudge email encouraging discussion to initiate discussion on SIC at next visit"

OTHER

Patient Nudge Letter and Share questionaire

"Involves patient nudge consists of a letter and SHARE questionnaire~\- patient nudge is a letter and a SHARE questionnaire encourages the participant to complete the SHARE questionnaire, which asks questions about the participants goals and preferences around cancer care, and discuss the questionnaire with their oncology clinician at the next visit."

Trial Locations (1)

02115

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER